CORDIS
EU research results

CORDIS

English EN

A disruptive, life-saving solution for home monitoring and management of lung fluid congestion in heart failure patients

Project information

Grant agreement ID: 878324

Status

Closed project

  • Start date

    1 September 2019

  • End date

    31 December 2019

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

SENSIBLE MEDICAL INNOVATIONS LTD

Israel

Project description

English EN

AI for lung fluid congestion monitoring

Heart failure (HF) is one of the most frequent causes of hospitalisation and premature death around the world. Patients who survive HF and return home need to remain under continuous monitoring so that any complications from lung fluid congestion are immediately treated. Unfortunately, these are often diagnosed very late. The EU-funded ReDS project is developing a medical device enabling easy, quick monitoring of lung congestion from the patient's home. It's non-invasive, connected with an artificial intelligence-based platform that manages collected data and sends it automatically to the care-centre. A special algorithm helps the doctor to prescribe proper treatment according to a patient's situation.

Coordinator

SENSIBLE MEDICAL INNOVATIONS LTD

Address

Meir Ariel 6
4059300 Netanya

Israel

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 50 000

Project information

Grant agreement ID: 878324

Status

Closed project

  • Start date

    1 September 2019

  • End date

    31 December 2019

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

SENSIBLE MEDICAL INNOVATIONS LTD

Israel